They were able to associate increased levels of ZEB1 with lymph node metastasis and advanced disease stage, proposing ZEB1 as an additional prognostic marker in breast carcinoma. The gene discussed is ZEB1; the disease is metastatic malignant neoplasm in the lymph nodes.